Home › Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval Of EVOMELA (melphalan) For Injection
 

Keywords :   


Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval Of EVOMELA (melphalan) For Injection

2016-03-30 07:12:27| drugdiscoveryonline Home Page

Ligand Pharmaceuticals Incorporated announces thatSpectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, received approval from the U.S. Food and Drug Administration (FDA) of EVOMELA

Tags: partner approval spectrum receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.11Spain fines budget airlines including Ryanair 179m
22.11Eastern North Pacific Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
22.11Rush PANTS
22.11SBS
22.11/
22.11 YOU
22.11
More »